NUWE Stock Quote
| Symbol: | NUWE |
|---|---|
| Quote: | 0.98 |
| Change: | -0.04 |
| Change %: | -3.92% |
| High: | 0.98 |
| Low: | 0.95 |
| Open: | 0.97 |
|---|---|
| Volume: | 11,273 |
| 52 Week: | 0.75-12.60 |
| P/E Ratio: | -0.12 |
| EPS: | -8.41 |
| Market Cap: | 4.29 M |
Company Report
Nuwellis, Inc. is a distinguished medical device company specializing in the development, manufacturing, and global distribution of innovative products for ultrafiltration therapy. The company's flagship offerings, the Aquadex FlexFlow and Aquadex SmartFlow systems, are pivotal in treating patients suffering from fluid overload who have not responded adequately to diuretic therapy. The Aquadex FlexFlow system comprises a console, disposable blood set, and catheter, designed to provide effective and precise fluid management solutions.
Headquartered in Eden Prairie, Minnesota, Nuwellis markets its products directly to hospitals and clinics across the United States through a dedicated salesforce. Internationally, the company leverages a network of independent specialty distributors spanning key markets in Europe, Asia, and the Middle East, including Austria, Brazil, India, Israel, and the United Kingdom. This strategic approach ensures broad accessibility to its advanced medical technologies, supporting healthcare providers worldwide in delivering optimal patient care.
Founded in 1999 and formerly known as CHF Solutions, Inc., Nuwellis rebranded in April 2021 to reflect its expanded focus and commitment to advancing ultrafiltration therapy solutions. With a strong foundation in research and development, Nuwellis continues to drive innovation in medical devices, aiming to enhance patient outcomes and quality of life globally.
NUWE EPS Chart
NUWE Revenue Chart
NUWE Profile
| Exchange: | NASDAQ |
|---|---|
| Beta: | 0.505 |
| Industry: | Medical - Devices |
| Sector: | Healthcare |
| Employees: | 38 |
| IPO Date: | Feb 16, 2012 |
NUWE News
MINNEAPOLIS, April 24, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on fluid management solutions for patients with fluid overload, today announced the issuance of U.S. Patent No. 12,280,007 by the U.S. Patent and Trademark Office. The newly granted patent covers a fluid bag design that passively drai... 12 days ago |
MINNEAPOLIS, April 22, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a commercial-stage medical technology company focused on transforming the lives of people with fluid overload, today announced that it will release financial results for the first quarter 2025 on May 13, 2025. Nuwellis will host a conference call and webcast at 9:00 AM E... 14 days ago |
Nuwellis, Inc. (NASDAQ:NUWE ) Q4 2024 Earnings Conference Call March 11, 2025 9:00 AM ET Company Participants Vivian Cervantes - Gilmartin Group, Investor Relations John Erb - Interim President and Chief Executive Officer Rob Scott - Chief Financial Officer Conference Call Participants Jonathan Aschoff - Roth Anthony Vendetti - Maxim Group Operator... 1 months ago |
Nuwellis, Inc. (NUWE) came out with a quarterly loss of $0.23 per share versus the Zacks Consensus Estimate of a loss of $0.43. This compares to loss of $78.32 per share a year ago. 1 months ago |
MINNEAPOLIS, March 11, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a commercial-stage medical device company focused on transforming the lives of people with fluid overload, today reported financial results for the fourth quarter and full year ended December 31, 2024. 1 months ago |
Analyst Ratings